Sisram Medical Ltd SRAMF

Morningstar Rating
$0.06 −0.38 (87.41%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SRAMF is trading at a LOCK|x%%D< premium.
Price
$0.06
Fair Value
LOCK|vZnS@ws
Uncertainty
LOCK|%G&
1-Star Price
LOCK|nBFTg$
5-Star Price
LOCK|@W&#k&
Economic Moat
LOCK|%b
Capital Allocation
—

Trading Information

Previous Close Price
$0.44
Day Range
$0.06–0.06
52-Week Range
$0.06–0.98
Bid/Ask
$0.03 / $1.50
Shares Outstanding
467.89M
Market Cap
$25.85M
Volume/Avg
1,901 / 1,901

Key Statistics

Price/Earnings (Normalized)
1.68
Price/Sales
0.07
Dividend Yield (Trailing)
21.95%
Dividend Yield (Forward)
21.95%
Dividend Payment Schedule
Sep
Total Yield
21.95%

Company Profile

Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The Company is involved in research, development, design, manufacture, sale and marketing of medical aesthetics and dental equipment, home use devices, injectables and cosmeceuticals products. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Copulla, and LMNT. It operates through the following geographical segments: North America which is its key revenue generating market, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
1,043

Valuation

Metric
SRAMF
Price/Earnings (Normalized)
1.68
Price/Book Value
0.05
Price/Sales
0.07
Price/Cash Flow
—
Price/Earnings
SRAMF

Financial Strength

Metric
SRAMF
Quick Ratio
1.60
Current Ratio
2.37
Interest Coverage
5.77
Quick Ratio
SRAMF

Profitability

Metric
SRAMF
Return on Assets (Normalized)
3.67%
Return on Equity (Normalized)
5.12%
Return on Invested Capital (Normalized)
4.84%
Return on Assets
SRAMF

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|F<^w%$bLOCK|qx%?%$179B
Medtronic PLC
MDT
LOCK|$bCcW$PLOCK|>@pn?$122B
Stryker Corp
SYK
LOCK|@!B%&?$LOCK|#f%$118B
Boston Scientific Corp
BSX
LOCK|cjXKBHnLOCK|@gPfv$66B
Edwards Lifesciences Corp
EW
LOCK|hXzVK&hLOCK|f%Yyj$51B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|QB$$r^LOCK|!L$32B
DexCom Inc
DXCM
LOCK|#T<pS!w&LOCK|gpGw$29B
Koninklijke Philips NV ADR
PHG
LOCK|&%ZLOCK|<h$26B
Steris PLC
STE
LOCK|&%cvB<LOCK|NW^$$23B
Zimmer Biomet Holdings Inc
ZBH
LOCK|qx#w$XxgLOCK|GH^$19B

Sponsor Center